Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 14, 2005 - Issue 6
Submit an article Journal homepage
41
Views
16
CrossRef citations to date
0
Altmetric
Review

Beyond 5-fluorouracil: new horizons in systemic therapy for advanced colorectal cancer

Kenneth Khamly Division of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, Locked Bag 1, A’Beckett Street, Victoria 8006, Australia. [email protected]
,
Michael Jefford Division of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, Locked Bag 1, A’Beckett Street, Victoria 8006, Australia. [email protected]
,
Michael Michael Division of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, Locked Bag 1, A’Beckett Street, Victoria 8006, Australia. [email protected]
&
John Zalcberg Division of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, Locked Bag 1, A’Beckett Street, Victoria 8006, Australia. [email protected]
Pages 607-628 | Published online: 11 Jul 2005

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Kenneth Khamly, Michael Jefford, Michael Michael & John Zalcberg. (2006) Recent developments in the systemic therapy of advanced gastroesophageal malignancies. Expert Opinion on Investigational Drugs 15:2, pages 131-153.
Read now

Articles from other publishers (15)

A. S. Chiriapkin. (2022) REVIEW OF PYRIMIDINE DERIVATIVES AS PHARMACOLOGICALLY ACTIVE COMPOUNDS. Juvenis Scientia 8:5, pages 16-30.
Crossref
Shahab Uddin, Azhar R. Hussain, Maqbool Ahmed, Nasser Al-Sanea, Alaa Abduljabbar, Luai H. Ashari, Samar Alhomoud, Fouad Al-Dayel, Prashant Bavi & Khawla S. Al-Kuraya. (2011) Coexpression of Activated c-Met and Death Receptor 5 Predicts Better Survival in Colorectal Carcinoma. The American Journal of Pathology 179:6, pages 3032-3044.
Crossref
Zhiwei Yu, Binbin Cui, Yinghu Jin, Haipeng Chen & Xishan Wang. (2011) Novel irreversible EGFR tyrosine kinase inhibitor 324674 sensitizes human colon carcinoma HT29 and SW480 cells to apoptosis by blocking the EGFR pathway. Biochemical and Biophysical Research Communications 411:4, pages 751-756.
Crossref
Prashant Bavi, Shahab Uddin, Maqbool Ahmed, Zeenath Jehan, Rong Bu, Jehad Abubaker, Mehar Sultana, Nasser Al-Sanea, Alaa Abduljabbar, Luai H. Ashari, Samar Alhomoud, Fouad Al-Dayel, Sarita Prabhakaran, Azhar R. Hussain & Khawla S. Al-Kuraya. (2011) Bortezomib Stabilizes Mitotic Cyclins and Prevents Cell Cycle Progression via Inhibition of UBE2C in Colorectal Carcinoma. The American Journal of Pathology 178:5, pages 2109-2120.
Crossref
Shahab Uddin, Maqbool Ahmed, Azhar Hussain, Jehad Abubaker, Nasser Al-Sanea, Alaa AbdulJabbar, Luai H. Ashari, Samar Alhomoud, Fouad Al-Dayel, Zeenath Jehan, Prashant Bavi, Abdul K. Siraj & Khawla S. Al-Kuraya. (2011) Genome-Wide Expression Analysis of Middle Eastern Colorectal Cancer Reveals FOXM1 as a Novel Target for Cancer Therapy. The American Journal of Pathology 178:2, pages 537-547.
Crossref
Dan Cao, Mei Hou, Yong-song Guan, Ming Jiang, Yu Yang & Hong-feng Gou. (2009) Expression of HIF-1alpha and VEGF in colorectal cancer: association with clinical outcomes and prognostic implications. BMC Cancer 9:1.
Crossref
Shahab Uddin, Azhar R Hussain, Maqbool Ahmed, Jehad Abubaker, Nasser Al-Sanea, Alaa AbdulJabbar, Luai H Ashari, Samar Alhomoud, Fouad Al-Dayel, Prashant Bavi & Khawla S Al-Kuraya. (2009) High Prevalence of Fatty Acid Synthase Expression in Colorectal Cancers in Middle Eastern Patients and Its Potential Role as a Therapeutic Target. The American Journal of Gastroenterology 104:7, pages 1790-1801.
Crossref
Shahab Uddin, Maqbool Ahmed, Prashant Bavi, Raafat El-Sayed, Nasser Al-Sanea, Alaa AbdulJabbar, Luai H. Ashari, Samar Alhomoud, Fouad Al-Dayel, Azhar R. Hussain & Khawla S. Al-Kuraya. (2008) Bortezomib (Velcade) Induces p27Kip1 Expression through S-Phase Kinase Protein 2 Degradation in Colorectal Cancer. Cancer Research 68:9, pages 3379-3388.
Crossref
Jianping Chen, Melissa Smith, Kenneth Kolinsky, Violeta Adames, Nila Mehta, Luke Fritzky, Mohammad Rashed, Eric Wheeldon, Michael Linn & Brian Higgins. (2006) Antitumor activity of HER1/EGFR tyrosine kinase inhibitor erlotinib, alone and in combination with CPT-11 (irinotecan) in human colorectal cancer xenograft models. Cancer Chemotherapy and Pharmacology 59:5, pages 651-659.
Crossref
M.-C. Etienne-Grimaldi, A. Cayre, F. Penault-Llorca, M. Francoual, J.-L. Formento, D. Benchimol, A. Bourgeon & G. Milano. (2006) EGFR expression in colon cancer: a break in the clouds. Annals of Oncology 17:12, pages 1850-1851.
Crossref
Erika Martinelli, Teresa Troiani, Floriana Morgillo, Maria Carmela Piccirillo, Katia Monaco, Maria Pia Morelli, Tina Cascone & Fortunato Ciardiello. (2006) Combination of epidermal growth factor receptor inhibitors and antiangiogenic drugs: a model for treatment. Targeted Oncology 1:3, pages 123-129.
Crossref
M. Francoual, M.-C. Etienne-Grimaldi, J.-L. Formento, D. Benchimol, A. Bourgeon, M. Chazal, C. Letoublon, T. André, N. Gilly, J.-R. Delpero, P. Lasser, J.-P. Spano & G. Milano. (2006) EGFR in colorectal cancer: more than a simple receptor. Annals of Oncology 17:6, pages 962-967.
Crossref
Gong Wu, Rolf F. Barth, Weilian Yang, Shinji Kawabata, Liwen Zhang & Kari Green-Church. (2006) Targeted delivery of methotrexate to epidermal growth factor receptor–positive brain tumors by means of cetuximab (IMC-C225) dendrimer bioconjugates. Molecular Cancer Therapeutics 5:1, pages 52-59.
Crossref
Norman Wolmark. (2005) Provocative Optimism in the Treatment of Early Stage Disease. The Oncologist 10:S2, pages 1-3.
Crossref
Floriana Morgillo & Ho-Young Lee. (2005) Resistance to epidermal growth factor receptor-targeted therapy. Drug Resistance Updates 8:5, pages 298-310.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.